Vivo Bio Tech Limited (BOM:511509)

Market Cap	583.46M
Revenue (ttm)	501.24M
Net Income (ttm)	40.88M
Shares Out	22.10M
EPS (ttm)	2.33
PE Ratio	11.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,313
Average Volume	31,610
Open	26.94
Previous Close	26.40
Day's Range	26.00 - 27.85
52-Week Range	25.21 - 56.90
Beta	0.17
RSI	18.02
Earnings Date	Nov 14, 2025

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In 2024, Vivo Bio Tech's revenue was 466.73 million, an increase of 2.69% compared to the previous year's 454.51 million. Earnings were 72.83 million, an increase of 188.27%.